Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO, Elliott M. Marcus, A. Venkatraman

Ophthalmology · 2005 · 669 citations · 49 references

DOIFull text

Open access

Concepts

References

49